Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Application
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Indapamide-13C-d3 is intended for use as an internal standard for the quantification of indapamide by GC- or LC-MS. Indapamide is a carbonic anhydrase (CA) inhibitor (Kis = 0.23, 36, 10, and 13 nM for CAVII, CAIX, CAXII, and CAXIII, respectively).1 It is selective for these CAs over CAI-CAVI and CAXIV (Kis = 213->10,000 nM). Indapamide is a thiazide-like diuretic that reduces blood pressure in spontaneously hypertensive rats (SHRs).2 It also increases urinary and renovascular levels of 11,12-EET and 14,15-EET, decreases urinary levels of 11,12-DiHET and 14,15-DiHET, and reduces renal cortical malondialdehyde levels in SHRs. Formulations containing indapamide have been used in the treatment of hypertension, as well as salt and fluid retention associated with congestive heart failure.
WARNING This product is not for human or veterinary use.
1. Carbonic anhydrase inhibitors. Comparison of chlorthalidone and indapamide X-
2. Indapamide lowers blood pressure by increasing production of epoxyeicosatrienoic acids in the kidney. Mol. Pharmacol. 84(2), 286-295 (2013).